title: Nephroquiz 1: cyclophosphamide or mycofenolate mofetil?
authors.affiliation: Department of Medicine, Division of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Pasdaran, Tehran, Iran.
authors.forename: Fariba
authors.initials: F
authors.lastname: Samadian
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Parvin
authors.forename: Amirhossein
authors.initials: A
authors.lastname: Faraji
authors.forename: Pedram
authors.initials: P
authors.lastname: Ahmadpoor
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy; D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003657:Decision Making; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D009173:Mycophenolic Acid